investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best

ACTINIUM PHARMACEUTICALS INC
(00507W107)

Funds Reporting Holdings of ACTINIUM PHARMACEUTICALS INC according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
DA Davidson & Co 40,500 $10k Jun 30, 2019 Aug 13, 2019
Cetera Advisor Networks LLC 142,500 $49k Jun 30, 2019 Aug 12, 2019
Panagora Asset Management Inc 52,591 $13k Jun 30, 2019 Aug 9, 2019
Renaissance Technologies LLC 211,628 $52k Jun 30, 2019 Aug 12, 2019
Dowling & Yahnke LLC 22,870 $6k Jun 30, 2019 Jul 22, 2019
Baker Ellis Asset Management LLC 10,000 $2k Jun 30, 2019 Aug 12, 2019
Malaga COVE Capital LLC 30,000 $7k Jun 30, 2019 Aug 14, 2019
SNS Financial Group LLC 35,000 $9k Jun 30, 2019 Jul 26, 2019
Sabby Management LLC 8,343,716 $2,053k Jun 30, 2019 Aug 14, 2019
SIO Capital Management LLC 4,935,250 $1,214k Jun 30, 2019 Aug 14, 2019
Endurant Capital Management LP 2,481,355 $610k Jun 30, 2019 Aug 14, 2019
Summit X 35,000 $8k Jun 30, 2019 Aug 13, 2019
Truvestments Capital LLC 11,648 $3k Jun 30, 2019 Jul 15, 2019
Oppenheimer & Co Inc 236,281 $58k Jun 30, 2019 Aug 9, 2019
Wedbush Securities Inc 10,000 $2k Jun 30, 2019 Aug 1, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.

Copyright © 2019 by InvestingReview.org / All Rights Reserved.